Shin Poong has established a number of overseas branches.
SHINPOONG PHARM.CO.,LTD.

R&D

Pipeline

  • HOME
  • R&D
  • Pipeline
Preclinical Phase 1 Phase 2 Phase 3/4 Marketed
Cardiovascular disease

SP-8257

Stroke, Atherosclerosis

Otaplimastat (SP-8203)

Acute ischemic stroke

CandeAmlo®

Hypertensive disease

SP-8416

Heart failure

CandeAmlo plus™

Hypertensive disease

EzeRosu®

Hyperlipidemia

OTAPLIMASTAT ALS

Additional Indication
Bone related disease

Hyaltop®

Osteoarthritis

Hyalflex®

Osteoarthritis
Medical Device

MEDIFLEX

Anti-adhesive

Medicurtain®

Anti-adhesive
Infectious disease

Pyramax® tablets

COVID-19

Drug repurposing

Pyramax® tablets

Malaria

WHO-MMV

Pyramax® granules

Malaria

WHO-MMV